Impact of different low-density lipoprotein (LDL) receptor mutations on the ability of LDL to support lymphocyte proliferation.
Based on the demand for cholesterol for membrane formation, we determined the ability of low-density lipoprotein (LDL) to support proliferation in lymphocytes bearing different LDL receptor mutations, which were treated "in vitro" with lovastatin to inhibit endogenous cholesterol synthesis. Peripheral lymphocytes were isolated from two patients with homozygous familial hypercholesterolemia (FH), one homozygote for the mutation N804K (FH(Colmenar)) in exon 17, herein described for the first time, and a compound heterozygote carrying the mutations D280G and G528V, which determine a transport-defective biochemical phenotype. Flow cytometric analysis with 1,1'-dioctadecyl-3,3,3,3'-tetramethylindocarbocyanineperchlorate (Dil)-LDL showed normal LDL binding but defective internalization in lymphocytes from case 1, whereas in lymphocytes from case 2 both LDL binding and internalization were affected. Studies with mitogen-stimulated lymphocytes demonstrated that despite the different phenotype, the ability of LDL to support proliferation was impaired in both cases to a similar extent. These results indicate that internalization of the LDL particle is required for expression of the mitogenic effect of LDL.
Martínez-Botas
J
J
Servicio de Bioquímica-Investigación, Hospital Ramón y Cajal, Madrid, Spain.
Suárez
Y
Y
Reshef
A
A
Carrero
P
P
Ortega
H
H
Gómez-Coronado
D
D
Teruel
J L
JL
Leitersdorf
E
E
Lasunción
M A
MA
D000293:Adolescent; D002455:Cell Division / Q000502:physiology; D005434:Flow Cytometry; D006720:Homozygote; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000097:blood* / Q000235:genetics*; D008077:Lipoproteins, LDL / Q000502:physiology*; D008214:Lymphocytes / Q000166:cytology*; D008297:Male; D009154:Mutation / Q000502:physiology*; D011973:Receptors, LDL / Q000235:genetics*
D008077:Lipoproteins, LDL; D011973:Receptors, LDL